StockNews.com started coverage on shares of LiqTech International (NASDAQ:LIQT – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the stock.
LIQT has been the topic of several other research reports. Lake Street Capital reduced their price objective on shares of LiqTech International from $9.00 to $6.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. Ascendiant Capital Markets restated a “buy” rating and issued a $5.15 price objective on shares of LiqTech International in a research report on Monday, August 26th.
Read Our Latest Analysis on LiqTech International
LiqTech International Stock Performance
Institutional Investors Weigh In On LiqTech International
A hedge fund recently raised its stake in LiqTech International stock. HighTower Advisors LLC boosted its position in shares of LiqTech International, Inc. (NASDAQ:LIQT – Free Report) by 40.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,599 shares of the company’s stock after purchasing an additional 11,043 shares during the period. HighTower Advisors LLC owned about 0.66% of LiqTech International worth $99,000 at the end of the most recent reporting period. 35.06% of the stock is currently owned by institutional investors and hedge funds.
About LiqTech International
LiqTech International, Inc, a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company operates through Water, Ceramics, and Plastics segments.
Recommended Stories
- Five stocks we like better than LiqTech International
- The Risks of Owning Bonds
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Following Congress Stock Trades
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 Small Caps With Big Return Potential
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for LiqTech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiqTech International and related companies with MarketBeat.com's FREE daily email newsletter.